Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

MCH Projects

The MCH Projects Database includes data on all Maternal and Child Health Bureau (MCHB) discretionary grantees funded through October 1, 2004, including Special Projects of Regional and National Significance (SPRANS), Community Integrated Service System (CISS) projects, Abstinence Education, and other programs funded outside Title V. It may be searched by name, location, keywords, and other fields. A list of selected final reports received in electronic formats is also available.

Descriptions of projects funded after 2004 are available from the Discretionary Grant Information System.

The primary audience for database information is MCHB central and regional staff, particularly staff from MCHB's Office of Program Development and from offices at the Health Resources and Services Administration and U.S. Department of Health and Human Services (DHHS) level. Reports containing MCHB project information are developed from the MCH Projects Databases and provide pertinent data for agency and bureau staff who are evaluating the MCH Projects Database or analyzing initiatives, policies, or programs.  In addition, project data are disseminated to Congressional members and other key maternal and child health (MCH) stakeholders.

The projects database includes information on projects in the following program areas:

Funded Within Title V

SPRANS: Approximately 15 percent of the Title V funds are allocated to SPRANS. Within SPRANS, there are five categories of projects:

  1. Research. MCHB funds applied research projects, not basic research. New knowledge and approaches acquired through these projects are intended to improve health care delivery systems for mothers and children.

  2. Training. MCH training grants address the need for skilled leadership personnel who can conduct effective and efficient MCH programs, and for developing and providing specialized support and services for these programs.

  3. Genetic Disease Testing, Counseling, and Information Dissemination. These projects serve individuals and families at risk for or affected by genetic disorders. The projects seek to integrate genetic services into other existing health service programs.

  4. Hemophilia Diagnostic and Treatment Centers. This category of SPRANS supports 10 regional programs that are linked to state Title V programs and other resources.

  5. Maternal and Child Health Improvement Projects (MCHIPs). Spanning a range of activities, MCHIPs support demonstrations of innovative services and new techniques for the delivery of services.

CISS: CISS is a second set-aside program. The goal of CISS is to reduce infant mortality and improve the health of mothers, pregnant women, and children through support for the development and expansion of community integrated service systems. These systems are public-private partnerships of health-related and other relevant organizations and individuals collaborating to use community resources to address community-identified health problems.

Abstinence Education: This grant program provides formula grants to states for abstinence education.

Funded Outside Title V

Emergency Medical Services for Children: This program provides funds to selected states to improve their capacity to respond to children's unique emergency medical needs.

Traumatic Brain Injury: This program of demonstration grants emphasizes states' activities to implement statewide systems that ensure access to comprehensive and coordinated traumatic brain injury services.

Healthy Start: Now in its replication phase, this initiative provides resources and technical assistance to 94 communities with high infant mortality rates.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.